Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00625001|
Recruitment Status : Unknown
Verified February 2008 by University of Aarhus.
Recruitment status was: Active, not recruiting
First Posted : February 28, 2008
Last Update Posted : February 28, 2008
Turner Syndrome (TS) is associated with osteopenia and osteoporosis. Reduced bone mineral density (BMD) and increased risk of fractures are present in many younger and middle-aged women with TS. The objective is therefore to describe longitudinal changes in BMD in TS.
The study is an observational follow-up study. Examinations at baseline, after 5 and 10 years.
Bone mineral density is measured by dual energy x-ray absorptiometry (DEXA) and bone turnover by bone markers.
Main Outcome Measures: Bone mineral density (BMD; grams/ square centimetre) were measured at lumbar spine, hip and the non-dominant forearm.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome|
|Study Start Date :||November 1994|
|Actual Primary Completion Date :||October 1996|
|Estimated Study Completion Date :||June 2010|
Women with Turner syndrome
Healthy control women
- Bone Mineral Density in columna lumbalis, collum femoris and distal ulnae Bone mineral density (BMD; grams/ square centimetre) were measured at lumbar spine, hip and the non-dominant forearm. [ Time Frame: Evey 5 years ]
Biospecimen Retention: Samples Without DNA